Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia

• Status: Completed
• Trial end date: 2012-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether All-trans retinoic acid (ATRA) are effective in the treatment of refractory idiopathic thrombocytopenic purpura (RITP).

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: First Affiliated Hospital of Suzhou Medical College
• Treatments: Tretinoin

Criteria

Inclusion Criteria:

• Clinical diagnosis of refratory idiopathic thrombocytopenic purpura

• Hormone and immune suppression, splenectomy is invalid

Exclusion Criteria:

• Other autoimmune diseases